AQST Operating Cash Flow (Statement)
Aquestive Therapeutics Inc · Operating Cash Flow (Statement)
AQST Operating Cash Flow (Statement)
Latest reported-$9.44Mperiod ending
AQST Quarterly Cash from Operations ($3.91M → -$9.44M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
AQST operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -9,441,000 | |
| -14,806,000 | |
| -8,469,000 | |
| -12,649,000 | |
| -7,914,000 | |
| -23,400,000 | |
| -6,489,000 | |
| -11,880,000 | |
| -7,006,000 | |
| -10,384,000 | |
| -4,942,000 | |
| -2,347,000 | |
| -7,907,000 | |
| 8,816,000 | |
| 8,446,000 | |
| 2,809,000 | |
| -6,562,000 | |
| -14,482,000 | |
| -8,061,000 | |
| -9,065,000 | |
| -1,756,000 | |
| -14,097,000 | |
| -13,512,000 | |
| -8,313,000 | |
| -9,997,000 | |
| -13,637,000 | |
| -10,575,000 | |
| -14,789,000 | |
| -17,166,000 | |
| -17,680,000 | |
| -2,812,000 | |
| -11,475,000 | |
| 511,000 | |
| 785,000 | |
| -7,409,000 | |
| 15,627,000 | |
| -6,302,000 | |
| 3,908,000 |